My Quote Request
6505-01-215-4147
20 Products
NDC11940-0103-06
OINTMENT BASE
NSN, MFG P/N
6505012154147
NSN
6505-01-215-4147
MFG
MEDCO LAB INC
Description
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 POUNDS
PRIMARY CONTAINER TYPE: JAR
SPECIAL FEATURES: CONTAINS STEARYL ALCOHOL,WHITE PETROLATUM,ISOPROPYL PALMITATE,SORBITOL,PROPYLENE GLYCOL,SODIUM LAURYL SULFATE,METHYLPARABEN,AND PROPYLPARABEN
Related Searches:
NDC16837-0610-12
ALUMINA,MAGNESIA,AND SIMETHICONE ORAL SUSPENSION,USP
NSN, MFG P/N
6505012154148
NSN
6505-01-215-4148
NDC16837-0610-12
ALUMINA,MAGNESIA,AND SIMETHICONE ORAL SUSPENSION,USP
NSN, MFG P/N
6505012154148
NSN
6505-01-215-4148
MFG
DPL ACE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS ALUMINUM HYDROXIDE GEL PER MILLILITER AND 40.000 MILLIGRAMS MAGNESIUM HYDROXIDE PER MILLILITER AND 4.000 TO 5.000 MG SIMETHICONE PER ML
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ALUMINUM MAGNESIUM HYDROXIDE GEL & SIMETHICONE SUSPENSION 12 FL OZ
PRIMARY CONTAINER CONTENT QUANTITY: 12.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00469-3300-60
POTASSIUM ACETATE INJECTION,USP
NSN, MFG P/N
6505012154150
NSN
6505-01-215-4150
NDC00469-3300-60
POTASSIUM ACETATE INJECTION,USP
NSN, MFG P/N
6505012154150
NSN
6505-01-215-4150
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIEQUIVALENTS POTASSIUM ACETATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM ACETATE INJECTION USP 4MEG/ML 50ML VIAL 25S PG
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00517-5024-25
POTASSIUM ACETATE INJECTION,USP
NSN, MFG P/N
6505012154150
NSN
6505-01-215-4150
NDC00517-5024-25
POTASSIUM ACETATE INJECTION,USP
NSN, MFG P/N
6505012154150
NSN
6505-01-215-4150
MFG
LUITPOLD PHARMACEUTICALS INC OSTEOHEALTH COMPANY OSTEOHEALTH DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIEQUIVALENTS POTASSIUM ACETATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM ACETATE INJECTION USP 4MEG/ML 50ML VIAL 25S PG
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00686-5024-25
POTASSIUM ACETATE INJECTION,USP
NSN, MFG P/N
6505012154150
NSN
6505-01-215-4150
NDC00686-5024-25
POTASSIUM ACETATE INJECTION,USP
NSN, MFG P/N
6505012154150
NSN
6505-01-215-4150
MFG
RAWAY PHARMACAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIEQUIVALENTS POTASSIUM ACETATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM ACETATE INJECTION USP 4MEG/ML 50ML VIAL 25S PG
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC63323-0033-50
POTASSIUM ACETATE INJECTION,USP
NSN, MFG P/N
6505012154150
NSN
6505-01-215-4150
NDC63323-0033-50
POTASSIUM ACETATE INJECTION,USP
NSN, MFG P/N
6505012154150
NSN
6505-01-215-4150
MFG
AMERICAN PHARMACEUTICAL PARTNERS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIEQUIVALENTS POTASSIUM ACETATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM ACETATE INJECTION USP 4MEG/ML 50ML VIAL 25S PG
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00028-0042-01
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012154389
NSN
6505-01-215-4389
NDC00028-0042-01
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012154389
NSN
6505-01-215-4389
MFG
CIBA-GEIGY CORP GEIGY PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: LONG ACTION METHOD:EXTENDED RELEASE;
THERAPEUTIC EQUIVALENT: GEIGY
Related Searches:
ANGIOVIST 370
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505012154392
NSN
6505-01-215-4392
ANGIOVIST 370
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505012154392
NSN
6505-01-215-4392
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V DIATRIZOATE SODIUM ACTIVE INGREDIENT AND 66.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,BERLEX LABS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 50
Related Searches:
NDC50419-0190-50
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505012154392
NSN
6505-01-215-4392
NDC50419-0190-50
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505012154392
NSN
6505-01-215-4392
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V DIATRIZOATE SODIUM ACTIVE INGREDIENT AND 66.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,BERLEX LABS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 50
Related Searches:
HI-210
INSULIN HUMAN INJECTION,USP
NSN, MFG P/N
6505012154825
NSN
6505-01-215-4825
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 UNITS INSULIN PER ML. ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INSULIN HUMAN INJECTION MODIFIED 100UN/ML VIAL
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING AND REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
III THERAPEUTIC EQUIVALENT: HUMULIN R BY LILLY
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: MULTIPLE-DOSE VIAL; RECOMBINANT DNA ORIGIN (E. COLI BACTERIA)
Related Searches:
HUMULIN-R
INSULIN HUMAN INJECTION,USP
NSN, MFG P/N
6505012154825
NSN
6505-01-215-4825
HUMULIN-R
INSULIN HUMAN INJECTION,USP
NSN, MFG P/N
6505012154825
NSN
6505-01-215-4825
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 UNITS INSULIN PER ML. ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INSULIN HUMAN INJECTION MODIFIED 100UN/ML VIAL
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING AND REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
III THERAPEUTIC EQUIVALENT: HUMULIN R BY LILLY
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: MULTIPLE-DOSE VIAL; RECOMBINANT DNA ORIGIN (E. COLI BACTERIA)
Related Searches:
NDC00002-8215-01
INSULIN HUMAN INJECTION,USP
NSN, MFG P/N
6505012154825
NSN
6505-01-215-4825
NDC00002-8215-01
INSULIN HUMAN INJECTION,USP
NSN, MFG P/N
6505012154825
NSN
6505-01-215-4825
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 UNITS INSULIN PER ML. ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INSULIN HUMAN INJECTION MODIFIED 100UN/ML VIAL
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING AND REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
III THERAPEUTIC EQUIVALENT: HUMULIN R BY LILLY
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: MULTIPLE-DOSE VIAL; RECOMBINANT DNA ORIGIN (E. COLI BACTERIA)
Related Searches:
NDC00169-1833-11
INSULIN HUMAN INJECTION,USP
NSN, MFG P/N
6505012154825
NSN
6505-01-215-4825
NDC00169-1833-11
INSULIN HUMAN INJECTION,USP
NSN, MFG P/N
6505012154825
NSN
6505-01-215-4825
MFG
NOVO NORDISK INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 UNITS INSULIN PER ML. ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INSULIN HUMAN INJECTION MODIFIED 100UN/ML VIAL
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING AND REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
III THERAPEUTIC EQUIVALENT: HUMULIN R BY LILLY
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: MULTIPLE-DOSE VIAL; RECOMBINANT DNA ORIGIN (E. COLI BACTERIA)
Related Searches:
1505
MAGNESIUM CITRATE ORAL SOLUTION,USP
NSN, MFG P/N
6505012157633
NSN
6505-01-215-7633
1505
MAGNESIUM CITRATE ORAL SOLUTION,USP
NSN, MFG P/N
6505012157633
NSN
6505-01-215-7633
MFG
NATIONAL MAGNESIA CO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 OUNCES MAGNESIUM CITRATE ACTIVE INGREDIENT
FLAVOR: LEMON
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: LOW SODIUM
Related Searches:
NDC00897-1505-20
MAGNESIUM CITRATE ORAL SOLUTION,USP
NSN, MFG P/N
6505012157633
NSN
6505-01-215-7633
NDC00897-1505-20
MAGNESIUM CITRATE ORAL SOLUTION,USP
NSN, MFG P/N
6505012157633
NSN
6505-01-215-7633
MFG
NATIONAL MAGNESIA CO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 OUNCES MAGNESIUM CITRATE ACTIVE INGREDIENT
FLAVOR: LEMON
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: LOW SODIUM
Related Searches:
NDC00472-1738-03
MICONAZOLE NITRATE VAGINAL SUPPOSITORIES,USP
NSN, MFG P/N
6505012157753
NSN
6505-01-215-7753
NDC00472-1738-03
MICONAZOLE NITRATE VAGINAL SUPPOSITORIES,USP
NSN, MFG P/N
6505012157753
NSN
6505-01-215-7753
MFG
DIXON-SHANE LLC DBA R & S NORTHEAST
Description
ACTIVE INGREDIENT AND STRENGTH: 200.000 MICONAZOLE NITRATE MILLIGRAMS
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MICONAZOLE NITRATE VAGINAL SUPPOSITORIES USP 200MG I.S. 3S
PRIMARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: SUPPOSITORIES PACKAGED WITH VAGINAL APPLICATOR
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
SUPPOSITORY TYPE: VAGINAL
Related Searches:
NDC55390-0103-10
ATRACURIUM BESYLATE INJECTION
NSN, MFG P/N
6505012157755
NSN
6505-01-215-7755
NDC55390-0103-10
ATRACURIUM BESYLATE INJECTION
NSN, MFG P/N
6505012157755
NSN
6505-01-215-7755
MFG
CARDINAL HEALTH INC. DBA CARDINAL HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS ATRACURIUM BESYLATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ATRACURIUM BESYLATE INJECTION 10MG/ML 10ML VIAL 10S
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: MULTIDOSE VIALS
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC61703-0313-32
ATRACURIUM BESYLATE INJECTION
NSN, MFG P/N
6505012157755
NSN
6505-01-215-7755
NDC61703-0313-32
ATRACURIUM BESYLATE INJECTION
NSN, MFG P/N
6505012157755
NSN
6505-01-215-7755
MFG
FAULDING PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS ATRACURIUM BESYLATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ATRACURIUM BESYLATE INJECTION 10MG/ML 10ML VIAL 10S
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: MULTIDOSE VIALS
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00182-0183-10
PREDNISOLONE TABLETS,USP
NSN, MFG P/N
6505012158102
NSN
6505-01-215-8102
NDC00182-0183-10
PREDNISOLONE TABLETS,USP
NSN, MFG P/N
6505012158102
NSN
6505-01-215-8102
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS PREDNISOLONE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
ANGIOVIST 370
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505012158103
NSN
6505-01-215-8103
ANGIOVIST 370
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505012158103
NSN
6505-01-215-8103
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V P-DITOLYMERCURY ACTIVE INGREDIENT AND DIATRIZOATE MEGLUMINE 66% V/W ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 20